InnoCan Pharma Corporation (QB) (INNPF)
USOTC
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -361.212 | -205.737 | -287.825 | -118.836 | -38.504 | -67.548 |
Return on Equity (%) | -1877.165 | -433.117 | 907.293 | -371.836 | -49.409 | -88.587 |
Return on Invested Capital (%) | -1836.22 | -371.18 | 392.673 | -272.237 | -76.553 | -70.4 |
Operating Margin (%) | N/A | N/A | -59062.5 | -3964.286 | -151.856 | -27.649 |
Net Profit Margin (%) | N/A | N/A | -124412.5 | -5126.02 | -147.089 | -34.415 |
Book Value Per Share | 0.955 | 0.01 | -0.019 | 0.036 | 0.025 | 0.016 |
Earnings Per Share | -8.962 | -0.023 | -0.053 | -0.04 | -0.015 | -0.018 |
Cash Per Share | 1.609 | 0.014 | 0.012 | 0.044 | 0.02 | 0.014 |
Working Capital Per Share | 1.383 | 0.009 | -0.019 | 0.036 | 0.025 | 0.016 |
Operating Profit Per Share | N/A | N/A | N/A | 0.001 | 0.009 | 0.045 |
EBIT Per Share | -8.962 | -0.023 | -0.053 | -0.041 | -0.016 | -0.015 |
EBITDA Per Share | -8.962 | -0.023 | -0.053 | -0.041 | -0.016 | -0.015 |
Free Cash Flow Per Share | -8.94 | -0.023 | -0.053 | -0.04 | -0.015 | -0.017 |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 133k | 143.87M | 188.32M | 248.5M | 249.73M | 268M |
Market Cap | 29.61M |
Price to Earnings Ratio | -6.59 |
Price to Sales Ratio | 2.26 |
Price to Cash Ratio | 7.97 |
Price to Book Ratio | 7.04 |
Dividend Yield | - |
Shares Outstanding | 280.66M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 100 |
52 Week Change | -51.65% |
52 Week High | 0.30 |
52 Week Low | 0.0908 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.